Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system.
about
Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expressionInterleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expressionPlasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer.Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosisUrokinase-type plasminogen activator receptor as a predictor of poor outcome in patients with systemic inflammatory response syndromeProteins and carbohydrates in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy.The hemostatic system and angiogenesis in malignancy.RNAi-mediated downregulation of urokinase plasminogen activator and its receptor in human meningioma cells inhibits tumor invasion and growth.Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3.Impaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator ExpressionPancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice.Membrane associated proteases and their inhibitors in tumour angiogenesis.Statins Increase Plasminogen Activator Inhibitor Type 1 Gene Transcription through a Pregnane X Receptor Regulated Element.The urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune system.Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.Ascites induces modulation of alpha6beta1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.Humoral innate immune response and disease.New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects.Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors.The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization.Role of urokinase receptor in tumor progression and development.Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoterA structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells.An ultra-sensitive immunoassay for quantifying biomarkers in breast tumor tissue.Transplantation of modified human adipose derived stromal cells expressing VEGF165 results in more efficient angiogenic response in ischemic skeletal muscle.Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
P2860
Q25257709-3DF7DD22-A3CF-4CBB-8D94-8E39B17B55EDQ28390678-ED65B483-02FB-4445-9785-BDBE97FDFC77Q30307084-70F23BE0-671A-4039-A676-12DEDB0AC232Q33376876-A48FE0DA-2526-4436-B893-7FDFBCA117F1Q33783271-7F4D39DD-4386-4DA7-8173-E67D3AA78F83Q34032235-084A77AE-4D73-487F-B9DC-2DE91A0BEB10Q34148127-4F8578C6-2E97-4ECB-ABC7-0DA9C6508973Q34425462-F7BEAF3F-C91D-4EF2-911C-3E461D44562FQ34601099-BFCAB7CC-61A4-464F-843F-62E345A31FEBQ34622476-36A9BC5F-C44D-484F-B956-3B3892A92EF9Q35034871-7198EE17-E949-438F-85D4-83B8E9D3DE96Q35130515-98D2A030-8769-47BB-BFCD-0B79994F5889Q35587684-650027AC-0747-4BFA-8EDE-0E97B3E53852Q35778684-CD29B47B-EB71-48DD-AA72-6A60676C160AQ36046670-0490BECB-5B0B-44EA-9EA5-860F5ED12632Q36302249-5C65B0CE-566F-45EA-8983-5CF1880DA928Q36616741-F23A1C7F-1921-4A0F-B68E-470112E34263Q36623129-7F4A6186-9158-4F8D-AB95-B9C5F6FC9CEEQ36648924-6CF3DAB8-8843-4BCC-B7F9-476CC1D2C5D5Q36696163-D3601D56-3118-400C-903F-5C0BB64A95E1Q36805290-4D66840D-F394-4D00-9244-EE517259001DQ36997616-0B0E8D20-3D66-4451-998A-D2922D9AD01EQ37424686-38E53BEE-9EA1-438C-B4A7-8B712EF8A0C7Q38601915-C90FCC0B-1277-4030-8AC6-E75EACE65A5BQ39458488-61FDBADF-FA35-49FD-B3F2-AC957A14BEBBQ41823150-483F6DB8-54DD-4F6B-BB0B-D37DE02821B8Q41905619-98D0A56A-6442-4CBA-9B20-D4C56940808FQ42151463-E15DD732-33A0-43B5-A3DD-81DF200B5B94Q51779283-4737E324-B8AE-47FE-9B75-1C470310B93C
P2860
Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Proteolysis, cell adhesion, ch ...... y the u-PA-u-PAR-PAI-1 system.
@ast
Proteolysis, cell adhesion, ch ...... y the u-PA-u-PAR-PAI-1 system.
@en
type
label
Proteolysis, cell adhesion, ch ...... y the u-PA-u-PAR-PAI-1 system.
@ast
Proteolysis, cell adhesion, ch ...... y the u-PA-u-PAR-PAI-1 system.
@en
prefLabel
Proteolysis, cell adhesion, ch ...... y the u-PA-u-PAR-PAI-1 system.
@ast
Proteolysis, cell adhesion, ch ...... y the u-PA-u-PAR-PAI-1 system.
@en
P1476
Proteolysis, cell adhesion, ch ...... y the u-PA-u-PAR-PAI-1 system.
@en
P2093
P304
P577
1999-08-01T00:00:00Z